Prognostic significance of low DICER expression regulated by miR-130a in cervical cancer

Cell Death and Disease

Volumn 5, Issue 5, 2014, Pages

  He, L ^a,b   Wang, H Y ^a   Zhang, L ^a   Huang, L ^a   Li, J D ^a   Xiong, Y ^a   Zhang, M Y ^a   Jia, W H ^a   Yun, J P ^a   Luo, R Z ^a   Zheng, M ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cervical cancer; Dicer; Microrna; MiR 130; Prognostic factor

Indexed keywords

DICER; LET 7A; MICRO RNA 130A; MICRORNA; MICRORNA 107; UNCLASSIFIED DRUG; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; MESSENGER RNA; MIRN130 MICRORNA, HUMAN; RIBONUCLEASE III;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; GENE CONTROL; GENETIC TRANSFECTION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KOLMOGOROV SMIRNOV TEST; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING; CELL MOTION; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; TUMOR INVASION; TUMOR RECURRENCE; UTERINE CERVIX TUMOR;

ADULT; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CLUSTER ANALYSIS; DEAD-BOX RNA HELICASES; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RIBONUCLEASE III; RNA, MESSENGER; ROC CURVE; UTERINE CERVICAL NEOPLASMS;

EID: 84900992995     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.127     Document Type: Article

References (37)

1. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007; 101: 59-68.
2. Tang KF, Wang Y, Wang P, Chen M, Chen Y, Hu HD et al. Upregulation of PHLDA2 in Dicer knockdown HEK293 cells. Biochim Biophys Acta 2007; 1770: 820.
3. Barbato C, Ciotti MT, Serafino A, Calissano P, Cogoni C. Dicer expression and localization in post-mitotic neurons. Brain Res 2007; 1175: 17-27.
4. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ et al. Dicer is essential for mouse development. Nat Genet 2003; 35: 215-217.
5. Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005; 96: 111-115.
6. Grelier G, Voirin N, Ay AS, Cox DG, Chabaud S, Treilleux I et al. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br J Cancer 2009; 101: 673-683.
7. Zighelboim I, Reinhart AJ, Gao F, Schmidt AP, Mutch DG, Thaker PH et al. DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma. Cancer 2011; 117: 1446-1453.
8. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008; 359: 2641-2650.
9. Behm-Ansmant I, Rehwinkel J, Izaurralde E. MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb Symp Quant Biol 2006; 71: 523-530.
10. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
11. Jannot G, Simard MJ. Tumour-related microRNAs functions in Caenorhabditis elegans. Oncogene 2006; 25: 6197-6201.
12. Vandenboom Ii TG, Li Y, Philip PA, Sarkar FH. MicroRNA and cancer: tiny molecules with major implications. Curr Genomics 2008; 9: 97-109.
13. Chen Y, Gorski DH. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008; 111: 1217-1226.
14. Wang XC, Tian LL, Wu HL, Jiang XY, Du LQ, Zhang H et al. Expression of miRNA-130a in nonsmall cell lung cancer. Am J Med Sci 2010; 340: 385-388.
15. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S et al. A MicroRNA targeting dicer for metastasis control. Cell 2010; 141: 1195-1207.
16. Tokumaru S, Suzuki M, Yamada H, Nagino M, Takahashi T. let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008; 29: 2073-2077.
17. Lui WO, Pourmand N, Patterson BK, Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 2007; 67: 6031-6043.
18. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008; 3: e2557.
19. Huang L, Lin J-X, Yu Y-H, Zhang M-Y, Wang H-Y, Zheng M et al. Down regulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix. PLoS One 2012; 7: e33762.
20. Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci USA 2008; 105: 14879-14884.
21. Li X, Zhang Y, Shi Y, Dong G, Liang J, Han Y et al. MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. J Cell Mol Med 2011; 15: 1887-1895.
22. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009; 41: 365-370.
23. Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM et al. Loss of heterozygosity for chromosome 14q in neuroblastoma. Med Pediatr Oncol 2001; 36: 28-31.
24. Buffart TE, Carvalho B, van Grieken NC, van Wieringen WN, Tijssen M, Kranenbarg EM et al. Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer. Oncologist 2012; 17: 653-662.
25. Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol Rep 2012; 27: 1759-1764.
26. Chen PS, Su JL, Cha ST, Tarn WY, Wang MY, Hsu HC et al. miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J Clin Invest 2011; 121: 3442-3455.
27. Shen SN, Wang LF, Jia YF, Hao YQ, Zhang L, Wang H. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagn Pathol 2013; 8: 69.
28. Luo M, Shen D, Zhou X, Chen X, Wang W. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Surgery 2013; 153: 836-847.
29. Liu L, Nie J, Chen L, Dong G, Du X, Wu X et al. The oncogenic role of microRNA-130a/ 301a/454 in human colorectal cancer via targeting Smad4 expression. PLoS One 2013; 8: e55532.
30. Qiu S, Lin S, Hu D, Feng Y, Tan Y, Peng Y. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients. J Transl Med 2013; 11: 10.
31. Boll K, Reiche K, Kasack K, Morbt N, Kretzschmar AK, Tomm JM et al. MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene 2013; 32: 277-285.
32. Kovaleva V, Mora R, Park YJ, Plass C, Chiramel AI, Bartenschlager R et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res 2012; 72: 1763-1772.
33. Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 2010; 467: 986-990.
34. He L, Ding H, Wang JH, Zhou Y, Li L, Yu YH et al. Overexpression of karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis. PLoS One 2012; 7: e42992.
35. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al. Combinatorial microRNA target predictions. Nature Genet 2005; 37: 495-500.
36. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
37. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic acids research 2008Nucleic Acids Res 36: D149-D153.